标题
Safety of drugs used for the treatment of Crohn’s disease
作者
关键词
-
出版物
Expert Opinion On Drug Safety
Volume 18, Issue 5, Pages 357-367
出版商
Informa UK Limited
发表日期
2019-04-27
DOI
10.1080/14740338.2019.1612874
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Long-term efficacy and safety of ustekinumab for Crohn's disease through the second year of therapy
- (2018) W. J. Sandborn et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Long-term efficacy and safety of ustekinumab in 122 refractory Crohn's disease patients: a multicentre experience
- (2018) P. Wils et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Lymphoma Risk and Overall Safety Profile of Adalimumab in Patients With Crohn’s Disease With up to 6 Years of Follow-Up in the Pyramid Registry
- (2018) Geert D’Haens et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- A real-world, long-term experience on effectiveness and safety of vedolizumab in adult patients with inflammatory bowel disease: The Cross Pennine study
- (2018) Marco Vincenzo Lenti et al. DIGESTIVE AND LIVER DISEASE
- Exposure Concentrations of Infants Breastfed by Women Receiving Biologic Therapies for Inflammatory Bowel Diseases and Effects of Breastfeeding on Infections and Development
- (2018) Rebecca Matro et al. GASTROENTEROLOGY
- What Is the Risk of Progressive Multifocal Leukoencephalopathy in Patients With Ulcerative Colitis or Crohn’s Disease Treated With Vedolizumab?
- (2018) Timothy Card et al. INFLAMMATORY BOWEL DISEASES
- Effectiveness and Safety of Vedolizumab in Anti-TNF-Naïve Patients With Inflammatory Bowel Disease—A Multicenter Retrospective European Study
- (2018) Uri Kopylov et al. INFLAMMATORY BOWEL DISEASES
- P140 Physician attitudes about the use of immunosuppressive therapy for inflammatory bowel disease in the elderly
- (2018) W P W Chan et al. Journal of Crohns & Colitis
- Respiratory Tract Infections in Patients With Inflammatory Bowel Disease: Safety Analyses From Vedolizumab Clinical Trials
- (2018) Brian G Feagan et al. Journal of Crohns & Colitis
- Systematic review with meta-analysis: real-world effectiveness and safety of vedolizumab in patients with inflammatory bowel disease
- (2018) Stefan Schreiber et al. JOURNAL OF GASTROENTEROLOGY
- Safety of Anti-TNF-Alpha Therapy During Pregnancy on Long-term Outcome of Exposed Children: A Controlled, Multicenter Observation
- (2018) Dana Duricova et al. INFLAMMATORY BOWEL DISEASES
- Thiopurines Dosed to a Therapeutic 6-Thioguanine Level in Combination with Adalimumab Are More Effective Than Subtherapeutic Thiopurine-based Combination Therapy or Adalimumab Monotherapy During Induction and Maintenance in Patients with Long-standing Crohnʼs Disease
- (2017) Viraj C. Kariyawasam et al. INFLAMMATORY BOWEL DISEASES
- Evaluation of the Quality of Semen and Sexual Function in Men with Inflammatory Bowel Disease
- (2017) Paz Valer et al. INFLAMMATORY BOWEL DISEASES
- Vedolizumab Is Safe and Effective in Elderly Patients with Inflammatory Bowel Disease
- (2017) Udayakumar Navaneethan et al. INFLAMMATORY BOWEL DISEASES
- Association Between Use of Thiopurines or Tumor Necrosis Factor Antagonists Alone or in Combination and Risk of Lymphoma in Patients With Inflammatory Bowel Disease
- (2017) Magali Lemaitre et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Vedolizumab Levels in Breast Milk of Nursing Mothers With Inflammatory Bowel Disease
- (2017) Adi Lahat et al. Journal of Crohns & Colitis
- Vedolizumab in IBD–Lessons From Real-world Experience; A Systematic Review and Pooled Analysis
- (2017) Tal Engel et al. Journal of Crohns & Colitis
- Association of Therapy for Autoimmune Disease With Myelodysplastic Syndromes and Acute Myeloid Leukemia
- (2017) Natalie Ertz-Archambault et al. JAMA Oncology
- The Real-World Effectiveness and Safety of Vedolizumab for Moderate–Severe Crohn’s Disease: Results From the US VICTORY Consortium
- (2016) Parambir S Dulai et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Therapeutic drug monitoring of anti-tumour necrosis factor-α agents in inflammatory bowel disease
- (2016) Nikola Mitrev et al. Expert Opinion On Drug Safety
- A safety assessment of anti-tumor necrosis factor alpha therapy for treatment of Crohn’s disease
- (2016) Konstantinos Papamichael et al. Expert Opinion On Drug Safety
- Concentrations of Adalimumab and Infliximab in Mothers and Newborns, and Effects on Infection
- (2016) Mette Julsgaard et al. GASTROENTEROLOGY
- The safety of vedolizumab for ulcerative colitis and Crohn's disease
- (2016) Jean-Frédéric Colombel et al. GUT
- Use of Methotrexate in the Treatment of Inflammatory Bowel Diseases
- (2016) Hans H. Herfarth et al. INFLAMMATORY BOWEL DISEASES
- Ustekinumab therapy for Crohn's disease during pregnancy: a case report and review of the literature
- (2016) X. Cortes et al. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
- Ustekinumab as Induction and Maintenance Therapy for Crohn’s Disease
- (2016) Brian G. Feagan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Excess risk of urinary tract cancers in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study
- (2015) A. Bourrier et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Effectiveness and Safety of Immunomodulators With Anti–Tumor Necrosis Factor Therapy in Crohn’s Disease
- (2015) Mark T. Osterman et al. Clinical Gastroenterology and Hepatology
- 379 Expression of NOTCH Signaling Molecules in Barrett's Associated Adenocarcinoma
- (2015) Dan Li et al. GASTROENTEROLOGY
- Identification of Patients With Variants in TPMT and Dose Reduction Reduces Hematologic Events During Thiopurine Treatment of Inflammatory Bowel Disease
- (2015) Marieke J.H. Coenen et al. GASTROENTEROLOGY
- Trough Concentrations of Infliximab Guide Dosing for Patients With Inflammatory Bowel Disease
- (2015) Niels Vande Casteele et al. GASTROENTEROLOGY
- Progressive multifocal leukoencephalopathy: current treatment options and future perspectives
- (2015) Dejan Pavlovic et al. Therapeutic Advances in Neurological Disorders
- Optimizing the use of biological therapy in patients with inflammatory bowel disease
- (2015) A. C. Moss Gastroenterology Report
- 865 PIANO: A 1000 Patient Prospective Registry of Pregnancy Outcomes in Women With IBD Exposed to Immunomodulators and Biologic Therapy
- (2015) Uma Mahadevan et al. GASTROENTEROLOGY
- Early Use of Thiopurines or Methotrexate Reduces Major Abdominal and Perianal Surgery in Crohnʼs Disease
- (2014) Viraj C. Kariyawasam et al. INFLAMMATORY BOWEL DISEASES
- Stopping, Continuing, or Restarting Immunomodulators and Biologics When an Infection or Malignancy Develops
- (2014) Jason M. Swoger et al. INFLAMMATORY BOWEL DISEASES
- A common missense variant in NUDT15 confers susceptibility to thiopurine-induced leukopenia
- (2014) Suk-Kyun Yang et al. NATURE GENETICS
- HLA-DQA1–HLA-DRB1 variants confer susceptibility to pancreatitis induced by thiopurine immunosuppressants
- (2014) Graham A Heap et al. NATURE GENETICS
- Adverse events in IBD: to stop or continue immune suppressant and biologic treatment
- (2014) Leon P McLean et al. Expert Review of Gastroenterology & Hepatology
- Systematic review: macrophage activation syndrome in inflammatory bowel disease
- (2013) W. Fries et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Safety of Anti-TNF Agents During Pregnancy and Breastfeeding in Women With Inflammatory Bowel Disease
- (2013) Javier P Gisbert et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Safety of Thiopurines and Anti-TNF-α Drugs During Pregnancy in Patients With Inflammatory Bowel Disease
- (2013) M J Casanova et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Risk of Lymphoma in Patients With Ulcerative Colitis Treated With Thiopurines: A Nationwide Retrospective Cohort Study
- (2013) Nabeel Khan et al. GASTROENTEROLOGY
- Combination Therapy With Infliximab and Azathioprine Is Superior to Monotherapy With Either Agent in Ulcerative Colitis
- (2013) Remo Panaccione et al. GASTROENTEROLOGY
- Increased Risk of Malignancy With Adalimumab Combination Therapy, Compared With Monotherapy, for Crohn's Disease
- (2013) Mark T. Osterman et al. GASTROENTEROLOGY
- Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease
- (2013) William J. Sandborn et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Case of Therapy-Related Myeloid Neoplasm in a Patient with Crohns Disease Treated with Azathioprine
- (2012) François Mullier et al. ACTA HAEMATOLOGICA
- Serious Infection and Mortality in Patients With Crohn's Disease: More Than 5 Years of Follow-Up in the TREAT™ Registry
- (2012) Gary R Lichtenstein et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Systematic Review and Meta-analysis on the Effects of Thiopurines on Birth Outcomes from Female and Male Patients with Inflammatory Bowel Disease
- (2012) Mona Akbari et al. INFLAMMATORY BOWEL DISEASES
- Ustekinumab Induction and Maintenance Therapy in Refractory Crohn's Disease
- (2012) William J. Sandborn et al. NEW ENGLAND JOURNAL OF MEDICINE
- Risk of Natalizumab-Associated Progressive Multifocal Leukoencephalopathy
- (2012) Gary Bloomgren et al. NEW ENGLAND JOURNAL OF MEDICINE
- Methotrexate-induced pneumonitis in Crohn's disease. Case report and review of the literature
- (2012) Nadia D'Andrea et al. MULTIDISCIPLINARY RESPIRATORY MEDICINE
- Increased Risk for Nonmelanoma Skin Cancers in Patients Who Receive Thiopurines for Inflammatory Bowel Disease
- (2011) Laurent Peyrin–Biroulet et al. GASTROENTEROLOGY
- The Safety and Tolerability of Methotrexate for Treating Patients With Crohnʼs Disease
- (2011) Nilesh Chande et al. JOURNAL OF CLINICAL GASTROENTEROLOGY
- Effects of TNF antagonists on sperm characteristics in patients with spondyloarthritis
- (2010) P. M. Villiger et al. ANNALS OF THE RHEUMATIC DISEASES
- Advanced Age Is an Independent Risk Factor for Severe Infections and Mortality in Patients Given Anti–Tumor Necrosis Factor Therapy for Inflammatory Bowel Disease
- (2010) Mario Cottone et al. Clinical Gastroenterology and Hepatology
- A Systematic Review of Factors That Contribute to Hepatosplenic T-Cell Lymphoma in Patients With Inflammatory Bowel Disease
- (2010) David S. Kotlyar et al. Clinical Gastroenterology and Hepatology
- Thiopurine therapy in inflammatory bowel disease patients: Analyses of two 8-year intercept cohorts
- (2010) B. Jharap et al. INFLAMMATORY BOWEL DISEASES
- Case Report: Fatal case of disseminated BCG infection in an infant born to a mother taking infliximab for Crohn's Disease
- (2010) Kuldeep Cheent et al. Journal of Crohns & Colitis
- Long-term follow-up of babies exposed to azathioprine in utero and via breastfeeding
- (2010) Sieglinde Angelberger et al. Journal of Crohns & Colitis
- Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease
- (2010) Jean Frédéric Colombel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Risk of Lymphoma Associated With Combination Anti–Tumor Necrosis Factor and Immunomodulator Therapy for the Treatment of Crohn's Disease: A Meta-Analysis
- (2009) Corey A. Siegel et al. Clinical Gastroenterology and Hepatology
- Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study
- (2009) Laurent Beaugerie et al. LANCET
- Azathioprine treatment during lactation
- (2008) L. A. CHRISTENSEN et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Thiopurine-Induced Myelotoxicity in Patients With Inflammatory Bowel Disease: A Review
- (2008) Javier P. Gisbert et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Efficacy and Safety of Tumor Necrosis Factor Antagonists in Crohn's Disease: Meta-Analysis of Placebo-Controlled Trials
- (2008) Laurent Peyrin–Biroulet et al. Clinical Gastroenterology and Hepatology
- Thiopurine hepatotoxicity in inflammatory bowel disease: the role for adding allopurinol
- (2008) Rupert WL Leong et al. Expert Opinion On Drug Safety
- Long-term safety of infliximab for the treatment of inflammatory bowel disease: a single-centre cohort study
- (2008) H Fidder et al. GUT
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now